125 related articles for article (PubMed ID: 29558146)
1. The Curious Case of the OZ439 Mesylate Salt: An Amphiphilic Antimalarial Drug with Diverse Solution and Solid State Structures.
Clulow AJ; Salim M; Hawley A; Gilbert EP; Boyd BJ
Mol Pharm; 2018 May; 15(5):2027-2035. PubMed ID: 29558146
[TBL] [Abstract][Full Text] [Related]
2. Impact of Ferroquine on the Solubilization of Artefenomel (OZ439) during in Vitro Lipolysis in Milk and Implications for Oral Combination Therapy for Malaria.
Salim M; Khan J; Ramirez G; Murshed M; Clulow AJ; Hawley A; Ramachandruni H; Beilles S; Boyd BJ
Mol Pharm; 2019 Apr; 16(4):1658-1668. PubMed ID: 30830789
[TBL] [Abstract][Full Text] [Related]
3. Lipid Compositions in Infant Formulas Affect the Solubilization of Antimalarial Drugs Artefenomel (OZ439) and Ferroquine during Digestion.
Salim M; Ramirez G; Peng KY; Clulow AJ; Hawley A; Ramachandruni H; Beilles S; Boyd BJ
Mol Pharm; 2020 Jul; 17(7):2749-2759. PubMed ID: 32574056
[TBL] [Abstract][Full Text] [Related]
4. Interactions of Artefenomel (OZ439) with Milk during Digestion: Insights into Digestion-Driven Solubilization and Polymorphic Transformations.
Salim M; Khan J; Ramirez G; Clulow AJ; Hawley A; Ramachandruni H; Boyd BJ
Mol Pharm; 2018 Aug; 15(8):3535-3544. PubMed ID: 29932660
[TBL] [Abstract][Full Text] [Related]
5. Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria.
Charman SA; Arbe-Barnes S; Bathurst IC; Brun R; Campbell M; Charman WN; Chiu FC; Chollet J; Craft JC; Creek DJ; Dong Y; Matile H; Maurer M; Morizzi J; Nguyen T; Papastogiannidis P; Scheurer C; Shackleford DM; Sriraghavan K; Stingelin L; Tang Y; Urwyler H; Wang X; White KL; Wittlin S; Zhou L; Vennerstrom JL
Proc Natl Acad Sci U S A; 2011 Mar; 108(11):4400-5. PubMed ID: 21300861
[TBL] [Abstract][Full Text] [Related]
6. Spray drying OZ439 nanoparticles to form stable, water-dispersible powders for oral malaria therapy.
Ristroph KD; Feng J; McManus SA; Zhang Y; Gong K; Ramachandruni H; White CE; Prud'homme RK
J Transl Med; 2019 Mar; 17(1):97. PubMed ID: 30902103
[TBL] [Abstract][Full Text] [Related]
7. Encapsulation of OZ439 into Nanoparticles for Supersaturated Drug Release in Oral Malaria Therapy.
Lu HD; Ristroph KD; Dobrijevic ELK; Feng J; McManus SA; Zhang Y; Mulhearn WD; Ramachandruni H; Patel A; Prud'homme RK
ACS Infect Dis; 2018 Jun; 4(6):970-979. PubMed ID: 29575888
[TBL] [Abstract][Full Text] [Related]
8. Machines vs Malaria: A Flow-Based Preparation of the Drug Candidate OZ439.
Lau SH; Galván A; Merchant RR; Battilocchio C; Souto JA; Berry MB; Ley SV
Org Lett; 2015 Jul; 17(13):3218-21. PubMed ID: 26079282
[TBL] [Abstract][Full Text] [Related]
9. Seeking the Elusive Long-Acting Ozonide: Discovery of Artefenomel (OZ439).
Kim HS; Hammill JT; Guy RK
J Med Chem; 2017 Apr; 60(7):2651-2653. PubMed ID: 28296396
[TBL] [Abstract][Full Text] [Related]
10. Cocrystal and Salt Forms of an Imidazopyridazine Antimalarial Drug Lead.
Noonan TJ; Chibale K; Cheuka PM; Bourne SA; Caira MR
J Pharm Sci; 2019 Jul; 108(7):2349-2357. PubMed ID: 30817923
[TBL] [Abstract][Full Text] [Related]
11. Importance of using physiologically relevant volume of dissolution medium to correlate the oral exposure of formulations of BMS-480188 mesylate.
Gu CH; Gandhi RB; Tay LK; Zhou S; Raghavan K
Int J Pharm; 2004 Jan; 269(1):195-202. PubMed ID: 14698591
[TBL] [Abstract][Full Text] [Related]
12. First-in-man safety and pharmacokinetics of synthetic ozonide OZ439 demonstrates an improved exposure profile relative to other peroxide antimalarials.
Moehrle JJ; Duparc S; Siethoff C; van Giersbergen PL; Craft JC; Arbe-Barnes S; Charman SA; Gutierrez M; Wittlin S; Vennerstrom JL
Br J Clin Pharmacol; 2013 Feb; 75(2):524-37. PubMed ID: 22759078
[TBL] [Abstract][Full Text] [Related]
13. Comparative antimalarial activities and ADME profiles of ozonides (1,2,4-trioxolanes) OZ277, OZ439, and their 1,2-dioxolane, 1,2,4-trioxane, and 1,2,4,5-tetraoxane isosteres.
Wang X; Dong Y; Wittlin S; Charman SA; Chiu FC; Chollet J; Katneni K; Mannila J; Morizzi J; Ryan E; Scheurer C; Steuten J; Santo Tomas J; Snyder C; Vennerstrom JL
J Med Chem; 2013 Mar; 56(6):2547-55. PubMed ID: 23489135
[TBL] [Abstract][Full Text] [Related]
14. Structure and interactions of charged triblock copolymers studied by small-angle X-ray scattering: dependence on temperature and charge screening.
Behrens MA; Lopez M; Kjøniksen AL; Zhu K; Nyström B; Pedersen JS
Langmuir; 2012 Jan; 28(2):1105-14. PubMed ID: 22136627
[TBL] [Abstract][Full Text] [Related]
15. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the QT effect of a combination of piperaquine and a novel anti-malarial drug candidate OZ439, for the treatment of uncomplicated malaria.
Darpo B; Ferber G; Siegl P; Laurijssens B; Macintyre F; Toovey S; Duparc S
Br J Clin Pharmacol; 2015 Oct; 80(4):706-15. PubMed ID: 25966781
[TBL] [Abstract][Full Text] [Related]
17. NaCl-triggered self-assembly of hydrophilic poloxamine block copolymers.
Bahadur A; Cabana-Montenegro S; Aswal VK; Lage EV; Sandez-Macho I; Concheiro A; Alvarez-Lorenzo C; Bahadur P
Int J Pharm; 2015 Oct; 494(1):453-62. PubMed ID: 26315124
[TBL] [Abstract][Full Text] [Related]
18. Solubilisation behaviour of poorly water-soluble drugs during digestion of solid SMEDDS.
Vithani K; Hawley A; Jannin V; Pouton C; Boyd BJ
Eur J Pharm Biopharm; 2018 Sep; 130():236-246. PubMed ID: 29981444
[TBL] [Abstract][Full Text] [Related]
19. Self-assembly of charged amphiphilic diblock copolymers with insoluble blocks of decreasing hydrophobicity: from kinetically frozen colloids to macrosurfactants.
Jacquin M; Muller P; Cottet H; Théodoly O
Langmuir; 2010 Dec; 26(24):18681-93. PubMed ID: 21105648
[TBL] [Abstract][Full Text] [Related]
20. Investigation of solubility and dissolution of a free base and two different salt forms as a function of pH.
Li S; Wong S; Sethia S; Almoazen H; Joshi YM; Serajuddin AT
Pharm Res; 2005 Apr; 22(4):628-35. PubMed ID: 15846471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
